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Socioeconomic status and cutaneous malignant 
melanoma 
In this review article, Idorn and Wulf from Denmark analyse 
the association of socioeconomic status (SES) with cutaneous 
malignant melanoma (CMM). They highlight that the largest 
increase in CMM incidence has been for individuals with high 
SES, in contrast to individuals with lower SES, who present 
with thicker tumours and have a higher risk of CMM-related 
death. This review highlights important aspects of the associ-
ation of SES with CMM. The authors identify several studies 
suggesting that SES is associated with intermittent ultra-violet 
radiation (UVR) exposure during recreational activities. They 
describe how intermittent UVR exposure is a well-known 
risk factor for CMM, which may explain the large increase in 
CMM on intermittently exposed body parts among individuals 
with high SES. However, they point out that these individu-
als also have better access to screening services, and that this 
may explain the high incidence of thin CMM in this group. 
Despite this, the authors go on to point out that the association 
between SES and CMM is also seen in countries with equal 
access to healthcare for all SES groups. This is interpreted as 
suggesting that understanding the seriousness and nature of 
the disease may also be of importance. Lastly, they consider 
whether the major increase in CMM incidence observed dur-
ing recent decades reﬂects a real increase in the occurrence 
of CMM, is the result of earlier diagnosis of CMM, or is partly 
an artefact explained by the diagnosis of ‘biologically benign 
CMM lesions’ due to increased awareness of the disease 
among healthcare professionals and the general population. 
Br J Dermatol 2014; 170: 789–795.
Intralesional steroid for orofacial 
granulomatosis
Fedele et al., from the Eastman Dental Hospital in London, 
assessed the long-term beneﬁts of intralesional triamcinolone 
on the unsightly swelling of orofacial granulomatosis (OFG). 
They also studied prognostic factors for this treatment. The 
research consisted of an observational study of a cohort of 
22 patients with OFG. The primary outcome was deﬁned as a 
statistically signiﬁcant decrease in disease severity post-treat-
ment. Statistically signiﬁcant association with prognostic fac-
tors was the secondary outcome. Statistical analysis included 
Wilcoxon signed-rank tests and logistic regression. Compared 
with pretreatment, the authors reported statistically signiﬁcant 
decreases in disease severity scores at all time points until 48 
months post-treatment. No adverse effects were reported. 
The authors stated that this study conﬁrmed the long-term 
effectiveness of intralesional triamcinolone in controlling the 
disﬁguring swelling of OFG. However, they went on to cau-
tion that inherent limitations of observational studies make 
it important to carry out randomized case–control trials to 
conﬁrm their data. Br J Dermatol 2014; 170: 796–803.
Uganda: HIV and itchy papules in the 
antiretroviral therapy era
Chua et al. start by stating that pruritic papular eruption (PPE) of HIV 
is common in HIV-infected populations living in the tropics, and 
it is reported to improve with antiretroviral therapy (ART). Indeed, 
its presence after at least 6 months of ART has been proposed as 
one of several markers of treatment failure. This study set out to 
determine the factors associated with PPE in HIV-infected persons 
receiving ART. A case–control study was carried out, nested within 
a 500-person cohort from a teaching hospital in Mbarara, Uganda. 
Forty-ﬁve cases and 90 controls were enrolled. Cases were required 
to have had ART for ≥ 15 months and an itchy papular rash for at 
least 1 month, with microscopic correlation by skin biopsy. Each 
case was individually matched with two controls for age, sex and 
ART duration. The results showed that 25 of 45 cases (56%) had 
microscopic ﬁndings consistent with PPE, deﬁned as PPE cases. At 
skin examination and biopsy (study enrolment), a similar propor-
tion of PPE cases and matched controls had plasma HIV RNA < 400 
copies mL−1 (96% vs. 85%, P = 0.31). The odds of being a PPE case 
increased fourfold with every log increase in viral load at ART ini-
tiation (P = 0.02) but not at study enrolment. CD4 counts at ART 
initiation and study enrolment, and CD4 gains, CD8+ T-cell activa-
tion and kynurenine–tryptophan ratios measured 6 and 12 months 
after ART commencement were not associated with PPE cases. The 
authors concluded that PPE in HIV-infected persons receiving ART 
for ≥ 15 months was associated with greater HIV viraemia at ART 
commencement, independent of CD4 count. They also stated that 
skin biopsies were important to distinguish between PPE and other 
itchy papular eruptions. Br J Dermatol 2014; 170: 834–841.
Western Australia Melanoma Health Study
Cadby et al. start this paper by stating that Breslow thickness is the 
most important predictor of survival in localized malignant mela-
noma. They go on to describe how a number of melanoma risk 
factors have been associated with Breslow thickness. However, the 
role of genetic loci has been little investigated to date. The authors 
aimed to investigate the association of known melanoma suscepti-
bility genetic loci with Breslow thickness. The participants were 800 
cases from the Western Australian Melanoma Health Study, who 
completed a questionnaire and provided a DNA sample. Genetic 
association analyses were performed between Breslow thickness 
and single-nucleotide polymorphisms (SNPs) from 15 candidate 
melanoma susceptibility genes, controlling for relevant covari-
ates. The authors found that older age at diagnosis and absence of 
naevi were associated with increased Breslow thickness. Following 
adjustment for multiple testing, no SNPs were significantly associ-
ated with Breslow thickness. They concluded that the associations 
observed between Breslow thickness, age and naevi reinforce cur-
rent knowledge and that some evidence of shared genetic determi-
nants between melanoma risk and Breslow thickness was found. 
They finish by stating that further studies are required to confirm 
these findings. Br J Dermatol 2014; 170: 853–859.
